SARS-CoV-2 candidate vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals a normal low range of viral backbone gene expression alongside very high levels of SARS-CoV-2 S glycoprotein expression.
Published in 1970 by
Abdulaziz Almuqrin,
Andrew D. Davidson,
Maia Kavanagh Williamson,
Phil Lewis,
Kate Heesom,
Susan Morris,
Sarah Gilbert,
David A. Matthews 
